Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
September 30, 2026 293.39M
June 30, 2026 323.11M
March 31, 2026 372.28M
December 31, 2025 411.10M
September 30, 2025 446.70M
June 30, 2025 189.24M
March 31, 2025 188.29M
Date Value
December 31, 2024 144.72M
September 30, 2024 186.69M
June 30, 2024 184.28M
March 31, 2024 181.99M
December 31, 2023 -0.0636M
December 31, 2022 -0.0219M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Korsana Biosciences, Inc. 416.53M
IRulya Therapeutics, Inc. 78.11M
PepGen Inc. 103.07M
Q32 Bio, Inc. 287.67M
Oncolytics Biotech, Inc. -7.503M

Shareholders Equity (Quarterly) Related Metrics